Literature DB >> 32773162

Additional observation of a de novo pathogenic variant in KCNT2 leading to epileptic encephalopathy with clinical features of frontal lobe epilepsy.

Luciana Midori Inuzuka1, Lucia Inês Macedo-Souza2, Bruno Della-Ripa2, Fabiola Paoli Monteiro3, Luiza Ramos3, João Paulo Kitajima3, Eliana Garzon4, Fernando Kok5.   

Abstract

INTRODUCTION: KCNT2 was recently recognized as a gene associated with neurodevelopmental disorder and epilepsy. CASE REPORT: We present an additional observation of a 16-year-old male patient with a novel de novo KCNT2 likely pathogenic variant and review the five previously reported cases of de novo variants in this gene. DISCUSSION: Whole exome sequencing identified the missense variant c.725C > A p.(Thr242Asn), which was confirmed by Sanger sequencing. Our patient has a refractory stereotyped and monomorphic type of hyperkinetic focal motor seizure, similar to what is seen in frontal lobe epilepsy, occurring only during sleep. This type of seizure is not usually seen in epileptic encephalopathies.
Copyright © 2020 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epilepsy; Epileptic Encephalopathy; KCNT2

Mesh:

Substances:

Year:  2020        PMID: 32773162     DOI: 10.1016/j.braindev.2020.05.003

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  2 in total

Review 1.  Next-Generation Sequencing Technologies and Neurogenetic Diseases.

Authors:  Hui Sun; Xiao-Rong Shen; Zi-Bing Fang; Zong-Zhi Jiang; Xiao-Jing Wei; Zi-Yi Wang; Xue-Fan Yu
Journal:  Life (Basel)       Date:  2021-04-19

2.  Case Report: Causative De novo Variants of KCNT2 for Developmental and Epileptic Encephalopathy.

Authors:  Pan Gong; Xianru Jiao; Dan Yu; Zhixian Yang
Journal:  Front Genet       Date:  2021-06-30       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.